Baseline Hepatitis C Virus Resistance-Associated Substitutions Present at Frequencies Lower Than 15% May Be Clinically Significant

Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s172226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

High Efficacy of Sofosbuvir/Velpatasvir and Impact of Baseline Resistance-Associated Substitutions in Hepatitis C Genotype 3 Infection

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Prevalence of Resistance Associated Substitutions and Efficacy of Baseline Resistance-Guided Chronic Hepatitis C Treatment in Spain From the GEHEP-004 Cohort

PLoS ONE
Multidisciplinary
2019English

Prevalence of Resistance-Associated Substitutions to Direct-Acting Antiviral Agents in Hemodialysis and Renal Transplant Patients Infected With Hepatitis C Virus

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

Clinically Unrecognized Myocardial Infarction Detected at MR Imaging May Not Be Associated With Atherosclerosis

Radiology
Nuclear MedicineRadiologyImaging
2007English

Are All rTMS Machines Equal? New Research Suggests There May Be Clinically Significant Differences

Mental Illness
PsychiatryMental Health
2019English

Hepatitis C Virus Resistance to Antiviral Therapy

Hepatology
MedicineHepatology
2000English

Nucleotide Substitutions of Hepatitis E Virus Genomes Associated With Fulminant Hepatitis and Disease Severity

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2009English

Unraveling the Structural Basis of Grazoprevir Potency Against Clinically Relevant Substitutions in Hepatitis C Virus NS3/4A Protease From Genotype 1a

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Guanosine Inhibits Hepatitis C Virus Replication and Increases Indel Frequencies, Associated With Altered Intracellular Nucleotide Pools

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy